These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1891512)

  • 1. Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
    Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL
    Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
    J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of umbilical plasma concentrations of catecholamines and their metabolites in patients with term vaginal deliveries].
    Ishizuka B; Hirata K; Matsumoto K; Ohno Y; Watanabe K; Kondoh T; Horikoshi H; Shiozaki K; Hamada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):729-34. PubMed ID: 1890351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
    Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H
    Arch Neurol; 1987 Apr; 44(4):423-8. PubMed ID: 2435272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo.
    Cucchi ML; Frattini P; Santagostino G; Orecchia G
    Pigment Cell Res; 2000 Feb; 13(1):28-32. PubMed ID: 10761993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of yohimbine in obsessive compulsive disorder.
    Rasmussen SA; Goodman WK; Woods SW; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1987; 93(3):308-13. PubMed ID: 2829264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
    Yoshimura R; Kaneko S; Shinkai K; Nakamura J
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of plasma catecholamine metabolites in normal subjects.
    Amin F; Hashmi A; Stroe AE; Adebogun O; Densmore D; Knott PJ
    Biol Psychiatry; 1998 Feb; 43(3):233-5. PubMed ID: 9494706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
    Umene-Nakano W; Yoshimura R; Yoshii C; Hayashi K; Ikenouchi-Sugita A; Katsuki A; Hori H; Nakamura J
    Nicotine Tob Res; 2012 Apr; 14(4):486-9. PubMed ID: 22006914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoreceptor status in obsessive-compulsive disorder.
    Lee MA; Cameron OG; Gurguis GN; Glitz D; Smith CB; Hariharan M; Abelson JL; Curtis GC
    Biol Psychiatry; 1990 May; 27(10):1083-93. PubMed ID: 2160292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine response and plasma catecholamines and their metabolites.
    Green AI; Alam MY; Sobieraj JT; Pappalardo KM; Waternaux C; Salzman C; Schatzberg AF; Schildkraut JJ
    Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats.
    Kvetnanský R; Fukuhara K; Pacák K; Cizza G; Goldstein DS; Kopin IJ
    Endocrinology; 1993 Sep; 133(3):1411-9. PubMed ID: 8396019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder.
    Fluitman SB; Denys DA; Heijnen CJ; Westenberg HG
    Psychoneuroendocrinology; 2010 Jul; 35(6):906-11. PubMed ID: 20044210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report.
    Orecchia G; Frattini P; Cucchi ML; Santagostino G
    Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid concentrations in patients with subarachnoid hemorrhage.
    Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H
    Stroke; 1987; 18(1):223-8. PubMed ID: 3810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
    Kirch DG; Jaskiw G; Linnoila M; Weinberger DR; Wyatt RJ
    Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenfluramine on plasma HVA in OCD.
    Hollander E; Stein DJ; Saoud JB; DeCaria CM; Cooper TB; Trungold S; Stanley M; Liebowitz MR
    Psychiatry Res; 1992 May; 42(2):185-8. PubMed ID: 1631253
    [No Abstract]   [Full Text] [Related]  

  • 20. [Catecholamines and their metabolites in children with Asperger and Kanner syndromes].
    Gorina AS; Kolesnichenko LS; Mikhnovich VI
    Biomed Khim; 2011; 57(5):562-70. PubMed ID: 22629607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.